EM-T3Expert Opinion on Drug Safety2024-07-301-6
Safety evaluation of the trastuzumab biosimilar in Iranian women with HER2-positive breast cancer undergoing adjuvant chemotherapy: a post-marketing surveillance
- Fatemeh ZahediQom University of Medical Science and Health Services
- Anya JafariShahid Beheshti University of Medical Sciences
- Behnam Nasiri Motlagh
- Seyed Hassan HamediShiraz University
- Roham SalekMashhad University of Medical Sciences
- Seyed Reza KhandooziGolestan University of Medical Sciences
- Negin FarshchianKermanshah University of Medical Sciences
- Soodabeh ShahidsalesMashhad University of Medical Sciences
- Ahmad R MafiShahid Beheshti University of Medical Sciences
- Sare HosseiniMashhad University of Medical Sciences
- Alireza Amouheidari
- Fatemeh Varshoee TabriziEmam Reza Hospital
- Nezhat KhanjaniShiraz University of Medical Sciences
- Niloofar AhmadlooShiraz University of Medical Sciences
- Mahdieh DayyaniEmam Reza Hospital
- Reza Khodabakhshi
- Mohammad Mahdi MojahedQom University of Medical Science and Health Services
- Masoumeh KeshvariShahid Beheshti University of Medical Sciences
- Mitra Fazl ErsiEmam Reza Hospital
- Marjaneh MirsadraeeEmam Reza Hospital
- Payam IzadpanahiEmam Reza Hospital
- Afshin Saadipoor
- Hamid NasrollahiShiraz University of Medical Sciences
- Robab AnbiaeeShahid Beheshti University of Medical Sciences
- Ali Emadi TorghabehMashhad University of Medical Sciences
- Alireza KeramatiBaqiyatallah University of Medical Sciences
- Seyed Ahmadreza AmiranKashan University of Medical Sciences
- Narges Bayat MokhtariEmam Reza Hospital
- Ali KermaniMashhad University of Medical Sciences
- Kazem AnvariMashhad University of Medical Sciences
- Mahboobeh Sadeghi IvariEmam Reza Hospital
- Malihe Dayani
- Amir AmirabadiIslamic Azad University, Mashhad
- Hamid Saeidi SaediGuilan University of Medical Sciences
- Araz SabzvariAlborz University of Medical Sciences
- Hamidreza Kafi
- Fatemeh Homaei ShandizShiraz University of Medical Sciences